- Stocks rose on Thursday after results showed Pfizer announced positive results on Wednesday to an early stage vaccination trial.
- Pfizer said patients created between 1.8 and 2.8 times the antibodies seen in those who have recovered from COVID-19.
- One market analyst said the "v-shaped recovery gnomes, are once again, reaching for the sky."
- But traders are awaiting US Non Farm Payroll data for further direction in the market.
- Visit Business Insider's homepage for more stories.
Global markets surged on Thursday as positive results from an early stage Pfizer coronavirus vaccine trial poured positive sentiment into markets, but traders looked to US Non Farm Payroll data due later today, for further direction.
All major stock indices, in Asia and Europe, as well as US futures were in green.
See the rest of the story at Business Insider
NOW WATCH: Pathologists debunk 13 coronavirus myths
See Also:
- The chief strategist of $2.5 trillion State Street recommends 7 ETFs for investors looking to profit from a permanently altered post-coronavirus landscape
- US consumer spending spiked a record 8.2% in May as personal incomes fell
- ECB's Lagarde says the worst of the coronavirus crisis has likely passed, but recovery will be a 'complicated matter'
from Business Insider https://ift.tt/2YSW2iA
No comments:
Post a Comment